Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I

Endocrinology

Volumn 150, Issue 12, 2009, Pages 5218-5229

  Böni Schnetzler, Marianne ^a   Boller, Simone ^a   Debray, Sarah ^b   Bouzakri, Karim ^c   Meier, Daniel T ^a   Prazak, Richard ^a   Kerr Conte, Julie ^d   Pattou, Francois ^d   Ehses, Jan A ^a   Schuit, Frans C ^b   Donath, Marc Y ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RELEASE; MACROPHAGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL;

EID: 71949118923     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0543     Document Type: Article

References (65)

1. Wellen KE, Hotamisligil GS 2005 Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119
2. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
3. Böni-Schnetzler M, Ehses JA, Faulenbach M, Donath MY 2008 Insulitis in type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):201-204
4. Ehses JA, Böni-Schnetzler M, Faulenbach M, Donath MY 2008 Macrophages, cytokines and β-cell death in type 2 diabetes. Biochem Soc Trans 36:340-342 (Pubitemid 351839327)
5. Böni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J, Pattou F, Halban PA, Weir GC, Donath MY 2008 Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93:4065-4074
6. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY 2002 Glucose-induced β-cell production of interleukin-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860 (Pubitemid 35050963)
7. Marselli L, Sgroi DC, Thorne J, Dahiya S, Torri S, Omer A, Del Prato S, Towia L, Otu HH, Sharma A, Bonner-Weir S, Marchetti P, Weir GC 2007 Evidence of inflammatory markers in β-cells of type 2 diabetic subjects. 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands, 2007, p 0418 (Abstract)
8. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, Donath MY 2007 Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356-2370 (Pubitemid 47358243)
9. Lorenzo A, Razzaboni B, Weir GC, Yankner BA 1994 Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756-760 (Pubitemid 24153418)
10. Homo-Delarche F, Calderari S, Irminger JC, Gangnerau MN, Coulaud J, Rickenbach K, Dolz M, Halban P, Portha B, Serradas P 2006 Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 55:1625-1633 (Pubitemid 44324114)
11. Dinarello CA 2009 Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550
12. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M 1986 Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545-1547 (Pubitemid 16061563)
13. Mandrup-Poulsen T 1996 The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029
14. Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, Théâtre E, Verhaeghe C, Magnusson NE, Chariot A, Orntoft TF, Eizirik DL 2008 Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic β-cells. Diabetologia 51:1213-1225
15. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526 (Pubitemid 46588416)
16. Donath MY, Weder C, Whitmore J, Bauer RJ, Der K, Scannon PJ, Dinarello CA, Solinger AM 2008 XOMA 052, an anti-IL-1β antibody, in a double-blind, placebo-controlled, dose escalation study of the safety and pharmacokinetics in patients with type 2 diabetes mellitus: a new approach to therapy. Diabetologia 51(Suppl 1):S7
17. Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K 2008 The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149:2208-2218 (Pubitemid 351574505)
18. Osborn O, Brownell SE, Sanchez-Alavez M, Salomon D, Gram H, Bartfai T 2008 Treatment with an interleukin 1β antibody improves glycemic control in diet-induced obesity. Cytokine 44:141-148
19. Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY 2009 IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 106:13998-14003
20. Ribaux P, Ehses JA, Lin-Marq N, Carrozzino F, Böni-Schnetzler M, Hammar E, Irminger JC, Donath MY, Halban PA 2007 Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic β-cells. Endocrinology 148:5582-5590 (Pubitemid 350012633)
21. Unger RH 1995 Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863-870
22. Boden G 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes [Erratum (1997) 46:536] 46:3-10 (Pubitemid 27009941)
23. Weir GC, Leahy JL, Bonner-Weir S 1986 Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab Rev 2:125-161 (Pubitemid 16079237)
24. Fei H, Zhao B, Zhao S, Wang Q 2008 Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1β-induced β-cell apoptosis. Mol Cell Biochem 315:75-84
25. Senn JJ 2006 Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 281:26865-26875
26. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025 (Pubitemid 44684486)
27. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A, Liu-Bryan R, Glass CK, Neels JG, Olefsky JM 2007 A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282:35279-35292 (Pubitemid 350232441)
28. Song MJ, Kim KH, Yoon JM, Kim JB 2006 Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739-745
29. Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, Häring HU 2004 Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53:3209-3216 (Pubitemid 39564497)
30. Koshkin V, Dai FF, Robson-Doucette CA, Chan CB, Wheeler MB 2008 Limited mitochondrial permeabilization is an early manifestation of palmitate-induced lipotoxicity in pancreatic β-cells. J Biol Chem 283:7936-7948
31. Kharroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL 2004 Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms: role of nuclear factor-κB and endoplasmic reticulum stress. Endocrinology 145:5087-5096 (Pubitemid 39551129)
32. Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY 2003 Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic β-cell turnover and function. Diabetes 52:726-733 (Pubitemid 36323580)
33. Haber EP, Procópio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R 2006 New insights into fatty acid modulation of pancreatic β-cell function. Int Rev Cytol 248:1-41 (Pubitemid 43238169)
34. Busch AK, Cordery D, Denyer GS, Biden TJ 2002 Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic β-cell function. Diabetes 51:977-987 (Pubitemid 34438339)
35. Bikopoulos G, da Silva Pimenta A, Lee SC, Lakey JR, Der SD, Chan CB, Ceddia RB, B Wheeler M, Rozakis-Adcock M 2008 Ex vivo transcriptional profiling of human pancreatic islets following chronic exposure to monounsaturated fatty acids. J Endocrinol 196:455-464
36. O'Neill LA 2008 The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226:10-18
37. Lee JY, Sohn KH, Rhee SH, Hwang D 2001 Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276:16683-16689 (Pubitemid 37411459)
38. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH 2004 Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279:16971-16979 (Pubitemid 38560450)
39. Boraschi D, Tagliabue A 2006 The interleukin-1 receptor family. Vitam Horm 74:229-254
40. Parnaud G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath MY, Bruun C, Mandrup-Poulsen T, Billestrup N, Halban PA 2008 Proliferation of sorted human and rat β-cells. Diabetologia 51:91-100 (Pubitemid 50002201)
41. Gmyr V, Belaich S, Muharram G, Lukowiak B, Vandewalle B, Pattou F, Kerr-Conte J 2004 Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9. Biochem Biophys Res Commun 320:27-33 (Pubitemid 38781780)
42. Ichii H, Pileggi A, Molano RD, Baidal DA, Khan A, Kuroda Y, Inverardi L, Goss JA, Alejandro R, Ricordi C 2005 Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 5:21-30 (Pubitemid 40095124)
43. Lukowiak B, Vandewalle B, Riachy R, Kerr-Conte J, Gmyr V, Belaich S, Lefebvre J, Pattou F 2001 Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 49:519-528 (Pubitemid 32295174)
44. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K 1990 Establishment of a pancreatic β-cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132 (Pubitemid 20228111)
45. Van Lommel L, Janssens K, Quintens R, Tsukamoto K, Vander Mierde D, Lemaire K, Denef C, Jonas JC, Martens G, Pipeleers D, Schuit FC 2006 Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes 55:3214-3220 (Pubitemid 44923576)
46. Ivarsson R, Quintens R, Dejonghe S, Tsukamoto K, In't Veld P, Renström E, Schuit FC 2005 Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54:2132-2142 (Pubitemid 40911277)
47. Schumann DM, Maedler K, Franklin I, Konrad D, Størling J, Böni-Schnetzler M, Gjinovci A, Kurrer MO, Gauthier BR, Bosco D, Andres A, Berney T, Greter M, Becher B, Chervonsky AV, Halban PA, Mandrup-Poulsen T, Wollheim CB, Donath MY 2007 The Fas pathway is involved in pancreatic β-cell secretory function. Proc Natl Acad Sci USA 104:2861-2866 (Pubitemid 46327970)
48. Arend WP, Malyak M, Guthridge CJ, Gabay C 1998 Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16:27-55 (Pubitemid 28183358)
49. Thorrez L, Van Deun K, Tranchevent LC, Van Lommel L, Engelen K, Marchal K, Moreau Y, Van Mechelen I, Schuit F 2008 Using ribosomal protein genes as reference: a tale of caution. PLoS ONE 3:e1854 (Pubitemid 351936461)
50. Hagenfeldt L, Wahren J, Pernow B, Räf L 1972 Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest 51:2324-2330
51. Bassilian S, Ahmed S, Lim SK, Boros LG, Mao CS, Lee WN 2002 Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis. Am J Physiol Endocrinol Metab 282:E507-E513 (Pubitemid 34654764)
52. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA, Donath MY 2004 Leptin modulates β-cell expression of IL-1 receptor antagonist and release of IL-1βin human islets. Proc Natl Acad Sci USA 101:8138-8143 (Pubitemid 38698067)
53. Kragh-Hansen U 1981 Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 33:17-53
54. Brikos C, Wait R, Begum S, O'Neill LA, Saklatvala J 2007 Mass spectrometric analysis of the endogenous type I interleukin-1 (IL-1) receptor signaling complex formed after IL-1 binding identifies IL-1RAcP, MyD88, and IRAK-4 as the stable components. Mol Cell Proteomics 6:1551-1559
55. Vives-Pi M, Somoza N, Fernández-Alvarez J, Vargas F, Caro P, Alba A, Gomis R, Labeta MO, Pujol-Borrell R 2003 Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet β-cells. Clin Exp Immunol 133:208-218 (Pubitemid 36918595)
56. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA 2008 Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 16:522-530 (Pubitemid 351328001)
57. Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H, Dinarello CA, Schaefer EJ 1993 Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest 92:105-113 (Pubitemid 23208986)
58. Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY 2001 Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function. Diabetes 50:69-76 (Pubitemid 32047983)
59. Maedler K, Schumann DM, Sauter N, Ellingsgaard H, Bosco D, Baertschiger R, Iwakura Y, Oberholzer J, Wollheim CB, Gauthier BR, Donath MY 2006 Low concentration of interleukin-1β induces FLICE-inhibitory protein-mediated β-cell proliferation in human pancreatic islets. Diabetes 55:2713-2722 (Pubitemid 44923669)
60. Deyerle KL, Sims JE, Dower SK, Bothwell MA 1992 Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol 149:1657-1665
61. Scarim AL, Arnush M, Hill JR, Marshall CA, Baldwin A, McDaniel ML, Corbett JA 1997 Evidence for the presence of type I IL-1 receptors on β-cells of islets of Langerhans. Biochim Biophys Acta 1361:313-320 (Pubitemid 27475310)
62. Blanco AM, Perez-Arago A, Fernandez-Lizarbe S, Guerri C 2008 Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. J Neurochem 106:625-639
63. Håversen L, Danielsson KN, Fogelstrand L, Wiklund O 2009 Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202:382-393
64. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772 (Pubitemid 47025442)
65. Cheng N, He R, Tian J, Ye PP, Ye RD 2008 Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181:22-26